Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Nurix Therapeutics, Inc. posts $12.68 million revenue in quarter ended Feb 28, 2023
By USInMinutes - Apr 13, 2023, 08:20 PM ET
Last Updated - Jul 18, 2023, 03:57 PM EDT
Key fundamental financials- loss of $40.73 million
- Revenue of $12.68 million
Nurix Therapeutics, Inc. [NRIX] has reported $40.73 million loss for the fiscal quarter ending Feb 28, 2023.
Revenue for the quarter was $12.68 million with operating income of $42.95 million.
The Sanfrancisco, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $274.05 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Sponsored
Read More from Quarterly Reports
Read More from USinMinutes
Popular News
Latest News